Subscribe To
Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25 Years of Manufacturing of Schedule 2 Products No Additional Investment Required to Support Clinical Trials for Psychedelic-Based Therapeutics SAN DIEGO and GAINESVILLE, Ga., July 26, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; Nasdaq: SCTL), a contract development and […] The post Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities t...
Read More
Posted: Jul 26 2023, 11:00
Author Name: forextv
Views: 102016